GMO Quality Fund
GQLIX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- Boston MA 02110 Boston MA United States of America 02110
- IPO Date
- Sep 27, 2019
- CIK
- 0000772129
- Website
- gmo.com
- Similar Companies
- Business
- GMO Quality Fund (GQLIX) is a mutual fund managed by GMO, a Boston-based asset management firm founded in 1977, that seeks long-term capital appreciation by investing primarily in high-quality, undervalued equity securities of companies worldwide. The fund employs a fundamental, value-oriented investment strategy focused on businesses with sustainable competitive advantages, strong balance sheets, and attractive valuations; it allocates across market capitalizations and sectors, including consumer staples, healthcare, industrials, and information technology, while maintaining a global portfolio with emphasis on the United States, Europe, and select emerging markets. GMO Quality Fund offers institutional share classes (GQLIX) and retail variants, with services including systematic risk management, quantitative screening for quality metrics such as return on capital and earnings stability, and active portfolio construction to mitigate downside risk. Headquartered in San Francisco with key operations in Boston and London, the fund targets sophisticated investors such as institutions and high-net-worth individuals seeking defensive growth in equity markets. In recent developments, GMO announced strategic enhancements to its equity strategies in 2024, including expanded integration of climate-aware quality factors and a new partnership with leading ESG data providers to refine stock selection; additionally, the firm completed a minor reorganization of its quality-focused offerings in early 2025, bolstering team expertise through key hires in quantitative research amid rising demand for resilient portfolios.